ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2663

Comparison of Clinical and Laboratory Profiles in 3575 Systemic Lupus Erythematosus Patients with and without Sjögren’s Syndrome: Data from the Spanish Society for Rheumatology Lupus Registry

Juan Gabriel Ovalles-Bonilla1,2, Francisco Javier López Longo3, Iñigo Rúa-Figueroa4, María Galindo5, Jaime Calvo-Alén6, Juan Carlos Nieto2, Julia Martínez-Barrio3, Roberto González7, Belen Serrano8, Iustina Janta2, Carlos M Gonzalez9, Indalecio Monteagudo2 and JM Pego-Reigosa10, 1Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain, 2Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 3Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 4Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, 5Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, 6Rheumatology Department, Hospital Universitario Araba. Vitoria-Gasteiz, Alava, Spain, 7Rheumatology, Hospital general Universitario Gregorio Marañón, Madrid, Spain, 8Rheumatology, Hospital General Universitario Gregorio Marañón, Genoa, Italy, 9Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 10Complexo Hospitalario Universitario de Vigo, Vigo, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Clinical, outcomes, serologic tests and systemic lupus erythematosus (SLE), Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster III: Treatment

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The clinical coexistence of Systemic Lupus Erythematosus (SLE) and Sjögren’s Syndrome (SS) was recognized in 1959. The prevalence of SS among patients with SLE varies considerably among the published studies (10-30%). There is still controversy as to whether or not SLE patients with overlapping SS have a distinct and significantly milder lupus. To address the clinical and serologic features of SLE and differences from SLE that occurs in overlap with SS.

Methods: This is a multicenter, descriptive, cross-sectional study of 3575 patients from the Spanish Society for Rheumatology Lupus Registry (RELESSER). Unselected SLE patients from 45 Rheumatology Departments across Spain were evaluated for the presence of overlapping SS using the American-European consensus criteria. Cumulative clinical data were collected at the moment of the last assessment. Clinical and laboratory parameters in SLE patients with SS (SLEwSS) were compared with those in SLE patients without SS (SLEwoSS).

Results: SS was identified in 516 SLE patients (14.4%). Compared with the SLEwoSS group, patients with SLEwSS were significantly older, had a higher frequency of mucocutaneous manifestations, Raynaud’s phenomenon, peripheral neuropathy, anti-Ro/SSA, anti-La/SSB, neoplasia, and older age at death, but had a significantly lower frequency of renal involvement, thrombocytopenia, anti-DNA, anti-β2-GPI IgM and complement consumption. Both groups displayed a clinically similar presentation of lymphadenopathy, systemic vasculitis, serositis, damage accrual, mortality, musculoskeletal and CNS manifestations.

Conclusion: SLEwSS appears to constitute a subgroup of SLE patients with distinct clinical and serologic features, in whom SS is expressed as an overlapping entity. A particular cluster of clinical variables, namely, mucocutaneous manifestations, Raynaud’s phenomenon, peripheral neuropathy, renal involvement and thrombocytopenia, was found to be important overall for discriminating SLE patients with or without SS. SLEwSS patients constitute a subgroup of patients with SLE characterized by milder lupus: older age at death, similar rates of mortality and SLICC-ACR damage index, less renal and immunological manifestations.

Image


Disclosure: J. G. Ovalles-Bonilla, None; F. J. López Longo, None; I. Rúa-Figueroa, None; M. Galindo, None; J. Calvo-Alén, None; J. C. Nieto, None; J. Martínez-Barrio, None; R. González, None; B. Serrano, None; I. Janta, None; C. M. Gonzalez, None; I. Monteagudo, None; J. Pego-Reigosa, None.

To cite this abstract in AMA style:

Ovalles-Bonilla JG, López Longo FJ, Rúa-Figueroa I, Galindo M, Calvo-Alén J, Nieto JC, Martínez-Barrio J, González R, Serrano B, Janta I, Gonzalez CM, Monteagudo I, Pego-Reigosa J. Comparison of Clinical and Laboratory Profiles in 3575 Systemic Lupus Erythematosus Patients with and without Sjögren’s Syndrome: Data from the Spanish Society for Rheumatology Lupus Registry [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/comparison-of-clinical-and-laboratory-profiles-in-3575-systemic-lupus-erythematosus-patients-with-and-without-sjogrens-syndrome-data-from-the-spanish-society-for-rheumatology-lupus-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-clinical-and-laboratory-profiles-in-3575-systemic-lupus-erythematosus-patients-with-and-without-sjogrens-syndrome-data-from-the-spanish-society-for-rheumatology-lupus-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology